Feasibility, Adherence, Acceptance and Usability of a Multimodal Telemonitoring for Pediatric Post-COVID Syndrome: A Bicentric Pilot Study.

Publication date: May 09, 2026

Existing healthcare infrastructure struggles to meet the complex care required for pediatric Post-COVID Syndrome (pPCS). Telemonitoring offers potential to enhance care access, reduce patient burden, and ensure continuity. This study introduces and evaluates a novel, multimodal telemonitoring concept for pPCS with high translational potential for broader pediatric chronic and post-infectious conditions. Telemonitoring included a patient app, digital sensors (spirometer, smartwatch), Patient Reported Outcome Measures, chat/video consultations (VC), and a medical telemonitoring platform. Patients aged 12-17 years with diagnosed PCS were recruited from two pPCS outpatient university clinics in Bielefeld and Munich, Germany. Monitoring lasted three months. Evaluation focused on feasibility, adherence, acceptance, and usability, using monitoring data, the System Usability Scale (SUS), Technology Usage Inventory (TUI), and a custom survey completed by patients and parents. 30 patients (mean age: 15y +/- 1. 9; 57% female (17/30); mean Baseline Bell-Score: 36. 4) and 30 parents participated. Adherence was high, with an average of 3. 4 (smartwatch) to 4. 6 (spirometry) measurements/week. Questionnaire response rate was 86% (411/480) and 97% (58/60) of VCs were conducted. SUS scores indicated very high usability (patients: 81. 25/100; parents: 75. 42/100). TUI results showed low skepticism, and high interest. Telemonitoring supported symptom management independent of in-person visits, despite sensor connectivity issues. This is the first study to demonstrate successful integration of telemonitoring in pPCS, with high adherence and positive feedback from all stakeholders supporting its potential. Despite occasional technical challenges and resource needs, this concept shows promise for broader hybrid telemonitoring care implementation in PCS and other post-infectious syndromes. TRIAL REGISTRATION: German Clinical Trials Register (DRKS), trial registration number: DRKS00029354. Registered 07 February 2023 – Retrospectively registered https://drks. de/search/en/trial/DRKS00029354/entails.

Open Access PDF

Concepts Keywords
Drks00029354 Adolescent
Germany Child
Outpatient COVID-19
Smartwatch Digital Medicine
Feasibility Studies
Female
Germany
Humans
Male
MHealth
Patient Compliance
Pediatrics
Pilot Projects
Post-COVID Syndrome
SARS-CoV-2
Telemedicine
Telemonitoring
Wearables

Semantics

Type Source Name
disease MESH Syndrome
disease MESH included
disease MESH PCS
disease MESH Myalgic Encephalomyelitis
disease MESH MDD
disease MESH PAIS
disease MESH Infection
disease MESH Postural Orthostatic Tachycardia Syndrome
disease MESH SARS CoV 2 infection
disease MESH fatigue
disease MESH brain fog
disease MESH dizziness
disease MESH pain
disease MESH mitochondrial dysfunction
disease MESH bed
drug DRUGBANK Methionine
drug DRUGBANK Cysteamine
drug DRUGBANK Tretamine
drug DRUGBANK Trestolone
disease MESH FSS
drug DRUGBANK Methyltestosterone
disease MESH SMS
disease MESH Anxiety
disease MESH allergies
disease MESH ers
disease MESH aAs
drug DRUGBANK Spinosad
drug DRUGBANK Indoleacetic acid
disease MESH heart failure
disease MESH eco
disease MESH Long COVID
disease MESH chronic illnesses
disease MESH Arts
pathway REACTOME Reproduction
drug DRUGBANK Adenosine
disease MESH myelitis
disease MESH Dysautonomia
disease MESH Dis
disease MESH dys
drug DRUGBANK Delorazepam
drug DRUGBANK Bismuth subgallate
drug DRUGBANK Diethylstilbestrol
disease MESH des
disease MESH Asthma
pathway KEGG Asthma
drug DRUGBANK Coenzyme M
disease MESH encephalomyelitis
disease MESH encephalopathy
drug DRUGBANK Alpha-1-proteinase inhibitor

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *